Archives

Fesarius Therapeutics demonstrates the science that establishes DermiSphere™ hDRT in a class of its own

B NEW YORK, April 30, 2026 /PRNewswire/ — FesariusTherapeutics, Inc., a commercial stage bioregenerative technology company focused on the development, manufacture and commercialization of solutions… Login to continue reading Login…

Read MoreFesarius Therapeutics demonstrates the science that establishes DermiSphere™ hDRT in a class of its own

Renibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting

P Clinical study in cardiac surgery patients demonstrates favorable safety profile; exploratory analyses suggest potential benefit in higher-risk populations SOUTHLAKE, Texas, April 30, 2026 /PRNewswire/… Login to continue reading Login…

Read MoreRenibus Therapeutics Announces Oral Presentation on Phase 3 PROTECT Trial Data for RBT-1 at the American Association for Thoracic Surgery (AATS) Annual Meeting

START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

B Strengthening clinical research capabilities in one of the nation’s most densely populated and high-opportunity oncology markets EAST BRUNSWICK, N.J., April 30, 2026 /PRNewswire/ —… Login to continue reading Login…

Read MoreSTART Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey